VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
ADSC01
Phase 2
Biologic
C
China Medical University Hospital
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
CTD-ILD
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
CTD-ILD
Phase 2
Recruiting
Clinical
Trials by Indication
[1]
CTD-ILD
1 trial
ADSCs Therapy in Patients With CTD-ILD
Recruiting
·
—
·
Phase 1/2
·
NCT06574581
·
16 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for ADSC01. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
ADSC01 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for ADSC01. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
China Medical University Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Phase 2
[1]
Company
C
China Medical University Hospital
Related News